about
Abnormal centrifugal axons in streptozotocin-diabetic rat retinasExpression pattern of sigma receptor 1 mRNA and protein in mammalian retinaLigation of CD40 in Human Müller Cells Induces P2X7 Receptor-Dependent Death of Retinal Endothelial Cells.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Increased intraretinal PO2 in short-term diabetic rats.The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.Diabetic eNOS-knockout mice develop accelerated retinopathy.Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice.Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levelsOmega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic miceMarrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in miceHigh glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy.Reduced insulin receptor signaling in retinal Müller cells cultured in high glucoseExamining the role of lipid mediators in diabetic retinopathy.Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy.Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscleIGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis.Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathyAnalysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice.Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathyNeural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.Classification of diabetic retinopathy and diabetic macular edema.Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathyNeuropeptides and diabetic retinopathy.Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy.Leveraging Optogenetic-Based Neurovascular Circuit Characterization for Repair.Retinal oxygen: from animals to humans.Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.Quantitative Assessment of Retinopathy Using Multi-parameter Image Analysis.TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis.Animal Models of Diabetic RetinopathyDevelopment of diabetes-induced acidosis in the rat retina.
P2860
Q28360675-46F94A40-362E-473A-9E37-1EEFE045AC34Q28362911-7748CDD1-93C2-48F6-9679-7DC824C194F9Q32185814-B5A61694-48E3-4DB0-ABC1-6F3DD84914B2Q33719419-7BCFAF79-74DA-47B2-9A88-AE9D5F1530D5Q34545528-45B2E43E-DD8F-44D2-8044-B230EF711CBCQ34645612-F77201AC-9E6B-46F3-B1F5-EF2DD193EC23Q34735429-6CF2D3D0-16A7-499C-990A-193BF4514AD6Q35591570-1EE6C982-8167-4814-87F5-BB3BC21158DBQ35717962-291BDFBD-0864-4B5C-903B-3AB0FF68DA7EQ35928442-6FD42422-00ED-47B9-A646-DF44FB0A62BFQ36015795-49B4DCF8-ABB5-4DA6-988C-115CC77490F3Q36041947-81554C00-83FE-41A9-9F5E-ABA9D090C92EQ36128700-C541748F-A468-4B4B-9AB9-5B81A5142F52Q36410673-324F169C-85CD-4E10-855C-6DA611448807Q36744177-FE5BBA02-291F-4536-9710-E479560CE66AQ36765801-4F67FF40-AA57-47AC-82BA-3BDA4E54BF85Q36808421-43B23564-66A0-447C-ACD1-21092C82957BQ36814613-2C0DCE04-1AA1-4621-B4C6-9C98865B3670Q37000197-BDA7AC84-CF90-4322-BF3D-3D4CC6B541E3Q37089139-78F1C304-7CF9-4D76-B141-6ECC43042342Q37098594-3610077D-10E6-43E6-836A-82D126A11E74Q37172896-840D631A-CA4E-4210-828B-7E87C8FBE193Q37193753-657BA5C6-EC17-42A8-B8D8-B74EE19AE155Q37328633-0A77F3A4-1346-41F0-A9DB-681E8AFA7343Q37356613-D40A5DC2-6E99-4738-B54D-8F0B298B8285Q37384532-548EF33E-FFD9-4FB8-89C2-D6D1395B63E8Q37417753-6875167C-2B96-437F-9AB0-9A91F2F2FB3CQ37418982-3837044A-C7E0-4039-9BF1-0FE6F861F947Q38011496-1760349C-BAA6-4F47-98A8-FF9BE2A21575Q38050159-6B40EEBB-9A28-49F7-8907-FFE143E934B0Q38108833-34016504-8909-41F7-A1FA-BC3037F0DAA2Q38199730-09594BF0-8F9B-4BEA-87AB-35F18311BE83Q38439326-3210E72D-019B-44FE-9FFF-7D5E7BF230FCQ38693884-68F52944-8BD4-4DD8-87EA-2FA4B200BA63Q38767522-C778C70E-BE09-471E-B501-CBA833A58EA4Q40557787-5360C106-63E1-4CEB-9705-33A43AA6653DQ40967738-73E8C9A0-7B30-4D2A-874F-6A09BE09AF92Q41363064-8F9BCFE9-6EBD-4996-BA1A-FDC0FE80727AQ41504603-0B111212-ECBD-476C-AAC0-E84261145AA7Q42388898-769C0F3F-B372-4B24-8093-0B0DA5AED5FF
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Retinopathy in animal models of diabetes.
@en
type
label
Retinopathy in animal models of diabetes.
@en
prefLabel
Retinopathy in animal models of diabetes.
@en
P1476
Retinopathy in animal models of diabetes.
@en
P2093
P304
P577
1995-07-01T00:00:00Z